In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive disease by 46% and ...

After forging unexpectedly fond ties with President Biden, Italy’s right-wing Premier Giorgia Meloni is poised to leverage a ...